MolNFT v1 · #98876 · protein
Development and preclinical characterization of a humanized antibody targeting CXCL12
4LMQ: “Development and preclinical characterization of a humanized antibody targeting CXCL12”. X-ray diffraction. MolNFT v1 #98876 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 4LMQ
- Type
- protein
- Length
- 956 residues
- Chains
- 6
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P48061
Structure
x-ray diffraction · 5 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| D | — | protein | 55 | — | P48061 |
| E | — | protein | 195 | — | — |
| F | — | protein | 58 | — | P48061 |
| H | — | protein | 220 | — | — |
| I, L | — | protein | 214 | — | — |
Compared structures
- 4LMQ · Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL12 · the same entry in another collection · chain L against L, TM-score 1.00
- P48061 · AlphaFold monomer V2.0 prediction for stromal cell-derived factor 1 (P48061) · a predicted model of the same protein · chain D against A, TM-score 0.85
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P48061
- Elsewhere: RCSB PDB 4LMQ · PDBe 4LMQ · UniProt P48061
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.